It is a small-molecule NNMT inhibitor being studied for its potential role in nicotinamide metabolism, NAD biology, methylation, fat-cell function, insulin sensitivity, and liver metabolism
Rybelsus (semaglutide) is a GLP-1 receptor agonist that enhances insulin secretion and slows gastric emptying, whilst Jardiance (empagliflozin) is an SGLT2 inhibitor that increases urinary glucose excretion
Following CDC guidance for testing and evaluation of potential infectious symptoms is appropriate in these situations
Consider ongoing counseling, support groups, or digital health programs focused on weight management and diabetes self-management
While they may not provide the same rapid results as prescription medications, they can be a sustainable and long-term solution
Most of the GLP-1 medications work only on the GLP-1 receptor